←
Shannon Fernando1,334 posts
Shannon Fernando avatar

Shannon Fernando

@shanfernands

Critical Care physician. Emergency physician. Researcher interested in all things resuscitation and critical care. Learning every day.

◷ Joined February 2017▧ 134 Photos and videos
Lakeridge Health avatar
⟳ Shannon Fernando retweeted
Lakeridge Health@LakeridgeHealth·Jul 28

Lakeridge Health is proud to celebrate a major research milestone as Dr. Shannon Fernando's @CIHR_IRSC Project Grant has been awarded $543,150 over three years through one of Canada's most competitive health research funding competitions.

Post attachment
Circulation avatar
⟳ Shannon Fernando retweeted
Circulation@CircAHA·May 5

#ICYMI: Long-Term Risk of Stroke After TIA or Minor Stroke @FaizanK91 @HotchkissBrain @UCalgaryMed @mihill68 @VYogendrakumar @draravindganesh @SimonFaHo @shanfernands @khanevski @rondalun1

#Systematic Review and Meta-analysis quantifies the relative contribution of prognostic factors to long-term stroke risk in patients with TIA or mini stroke, emphasizing the need for comprehensive assessment and individualized management. ahajrnls.org/3PjczsI

Post attachment
Spittin' Chiclets avatar
⟳ Shannon Fernando retweeted
Spittin' Chiclets@spittinchiclets·Apr 28

The mic cut out during O Canada, and the Buffalo crowd didn’t miss a beat 🇨🇦

1:11
Dr. Chacón-Lozsán F .'. avatar
⟳ Shannon Fernando retweeted
Dr. Chacón-Lozsán F .'.@franciscojlk·Apr 5

💙 Methylene blue in septic shock: miracle, myth… or misunderstood tool? We all know the scenario: 👉 Refractory vasoplegic shock 👉 Escalating norepinephrine 👉 Vasopressin, steroids… still hypotensive At some point, the question comes: Should we use methylene blue? ⚡ Mechanism Septic shock = NO-driven vasoplegia Methylene blue acts by: ❌ Inhibiting nitric oxide synthase (NOS) ❌ Blocking soluble guanylate cyclase ⬇️ Reducing cGMP ➡️ Restoring vascular tone 👉 A true catecholamine-sparing strategy 📊 What does the evidence say? Reality check: Use in practice is rare (~0.5% of septic shock patients) Often used as late salvage therapy Dosing strategies = highly variable But RCT signals are interesting: ↓ Vasopressor duration ↓ ICU / hospital length of stay Possible ↓ mortality (low certainty) 👉 Evidence is promising… but still weak 🚨 The clinical dilemma Timing is everything: Early use → potential physiologic benefit Late use → often too late to change trajectory 👉 Current practice is probably backwards ⚠️ What about safety? Potential concerns: Serotonin syndrome (with SSRIs) Pulmonary vasoconstriction G6PD-related hemolysis Interference with pulse oximetry 👉 Most serious effects seen with high doses 🧠 Take-home message > Methylene blue is not a “magic drug” but it may be a physiology-driven adjunct in vasoplegic shock ❓The real questions are: Who benefits? When to give it? At what dose? 🚀 Where we’re heading Ongoing trials (e.g., BLUSH trial) will clarify: ✔️ Early vs late use ✔️ Optimal dosing strategy ✔️ True impact on mortality 👉 This could redefine vasoplegic shock management 💡 Clinical reflection Next time you face refractory shock, ask: 👉 Is this still “fluid + catecholamine problem”… 👉 or already a NO-mediated vasoplegia problem? 📚 Reference Fernando, S. M.et al. Journal of Critical Care, 92, 155353. doi.org/10.1016/j.jcrc.2025.…

Post attachment
Shannon Fernando avatar
Shannon Fernando@shanfernands·Feb 4

A devastating loss. A brilliant clinician-scientist, and a genuinely amazing human being. I have no words.

It is so painful to share the news of @FralickMike sudden and unexpected passing 💔 Mike was an amazing, inspiring and generous person who touched the lives of many. As we mourn, please share and consider supporting his wife and 2-year-old daughter. gofund.me/236771146

Benjamin Hibbert avatar
⟳ Shannon Fernando retweeted
Benjamin Hibbert@benhibbertMDPhD·Feb 1

Another output from superstar fellow @JungRichardG - Prognostic factors associated with mortality in septic shock: a systematic review and meta-analysis - out in @LancetRespirMed Downloadable: authors.elsevier.com/a/1mWi%… Kudos to @SameerKadri12 for the accompanying editorial. In fields like cardiogenic (evidence.nejm.org/doi/full/1…) and septic shock we generate large amounts of prognostic data that live individually in studies published across time, journals etc. These findings have important implications for clinical and research applications but it can be difficult to understand these factors comparatively. In our publication, we boiled the data down to 95 eligible studies that included 4.8 million eligible patients. We divided the analysis into patient, presentation factors and biochemical markers as they related to in-hospital or 30-d mortality. Significant patient factors included black race, history of cirrhosis or malignancy. Significant presentation risk factors included respiratory source, AKD or elevated risk score (SOFA>APACHE>SAPSII) Significant treatment/biochemical risk factors included need for NE or mechanical ventilation. The identification of these prognostic factors could aid in clinical risk application, goals of care discussions, and identifying the subset of patients at highest and lowest risk of early mortality for patients with septic shock. Kudos to co-authors and collaborators @shanfernands @rebeccamathewmd @Bram_Rochwerg @PietroDiSantoMD @PietroDiSantoMD @GProsperiPorta @cameron_stotts #SEPSIS #SpesisAwareness #StopSepsis #critcare #criticalcare #ICU #CICU @MayoClinicCV @mayoclinicCCM @MayoPCCM @MayoCCJC @UOHI

Post attachmentPost attachmentPost attachment
Dr. Randy Wax avatar
⟳ Shannon Fernando retweeted
Dr. Randy Wax@drrandywax·Jan 29

Kudos to the author team including lead author @shanfernands from our @LakeridgeHealth @queensccm Critical Care faculty! Looking forward to the eventual results of the BLUSH trial underway to provide the randomized evidence needed to evaluate methylene blue in septic shock.

🔍 Methylene blue (MB) use is uncommon in septic shock, with substantial variability across time, patient populations, and hospitals. Randomized evidence is required to evaluate the efficacy and safety of MB. 📖 Read more in CCM: ow.ly/YoTN50Y432S #CritCareMed #SCCM @SCCM

Post attachment
MLB Network avatar
⟳ Shannon Fernando retweeted
MLB Network@MLBNetwork·28 Sep 2025

"I'm stunned that we're standing here talking about the Blue Jays winning the [AL] East." #MLBTonight reacts to Toronto's division clinch.

1:56